Drugs / Shouhui Tongbian Capsule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07534995 | May 2026 → Dec 2027 expected | opioid-induced constipation | First Teaching Hospital of Tianjin University of Traditional Chinese Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shouhui Tongbian Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07534995 ↗ |
| Route | Oral | “Administered orally: Shouhui Tongbian Capsule (specification: 0.35 g per capsule), 2 capsules each time, 3 times daily” NCT07534995 ↗ |